Literature DB >> 1414481

Axial and appendicular bone density predict fractures in older women.

D M Black1, S R Cummings, H K Genant, M C Nevitt, L Palermo, W Browner.   

Abstract

To determine whether measurement of hip and spine bone mass by dual-energy x-ray absorptiometry (DEXA) predicts fractures in women and to compare the predictive value of DEXA with that of single-photon absorptiometry (SPA) of appendicular sites, we prospectively studied 8134 nonblack women age 65 years and older who had both DEXA and SPA measurements of bone mass. A total of 208 nonspine fractures, including 37 wrist fractures, occurred during the follow-up period, which averaged 0.7 years. The risk of fracture was inversely related to bone density at all measurement sites. After adjusting for age, the relative risks per decrease of 1 standard deviation in bone density for the occurrence of any fracture was 1.40 for measurement at the proximal femur (95% confidence interval 1.20-1.63) and 1.35 (1.15-1.58) for measurement at the spine. Results were similar for all regions of the proximal femur as well as SPA measurements at the calcaneus, distal radius, and proximal radius. None of these measurements was a significantly better predictor of fractures than the others. Furthermore, measurement of the distal radius was not a better predictor of wrist fracture (relative risk 1.64: 95% CI 1.13-2.37) than other sites, such as the lumbar spine (RR 1.56; CI 1.07-2.26), the femoral neck (RR 1.65; CI 1.12-2.41), or the calcaneus (RR 1.83; CI 1.26-2.64). We conclude that the inverse relationship between bone mass and risk of fracture in older women is similar for absorptiometric measurements made at the hip, spine, and appendicular sites.

Entities:  

Keywords:  NASA Discipline Musculoskeletal; Non-NASA Center

Mesh:

Year:  1992        PMID: 1414481     DOI: 10.1002/jbmr.5650070607

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  88 in total

1.  Frequency dependence of ultrasonic backscatter from human trabecular bone: theory and experiment.

Authors:  K A Wear
Journal:  J Acoust Soc Am       Date:  1999-12       Impact factor: 1.840

Review 2.  Treatment induced changes of bone density and relative risk of vertebral fracture.

Authors:  S Adami; O Viapiana; F Corallo
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 3.  Current methods and advances in bone densitometry.

Authors:  G Guglielmi; C C Gluer; S Majumdar; B A Blunt; H K Genant
Journal:  Eur Radiol       Date:  1995       Impact factor: 5.315

4.  Prevalence of osteoporosis using bone mineral measurements at the calcaneus by dual X-ray and laser (DXL).

Authors:  R Kullenberg; J A Falch
Journal:  Osteoporos Int       Date:  2003-08-12       Impact factor: 4.507

5.  Bone density testing intervals and common sense.

Authors:  E Michael Lewiecki; Neil Binkley
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

6.  Design of the Fracture Intervention Trial.

Authors:  D M Black; T F Reiss; M C Nevitt; J Cauley; D Karpf; S R Cummings
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

7.  Effect of chronic activity-based therapy on bone mineral density and bone turnover in persons with spinal cord injury.

Authors:  Todd Anthony Astorino; Eric T Harness; Kara A Witzke
Journal:  Eur J Appl Physiol       Date:  2013-10-06       Impact factor: 3.078

Review 8.  Evaluation of therapeutic efficacy in osteoporosis.

Authors:  S Adami; S Ortolani; R Wasnich
Journal:  Osteoporos Int       Date:  1995-03       Impact factor: 4.507

9.  The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study.

Authors:  Silvano Adami; Sandro Giannini; Ruben Giorgino; GianCarlo Isaia; Stefania Maggi; Luigi Sinigaglia; Paolo Filipponi; Gaetano Crepaldi; Ombretta Di Munno
Journal:  Osteoporos Int       Date:  2003-04-11       Impact factor: 4.507

10.  Beneficial role of intravenous calcitriol on bone mineral density in children with severe secondary hyperparathyroidism.

Authors:  Esra Baskin; Seza Ozen; Musturay Karçaaltincaba; Nesrin Besbas; Umit Saatci; Ali Düzova; Pinar Isik Agras; Mithat Haliloglu; Aysin Bakkaloglu
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.